Product Details

Rezurock

Belumosudil
200 mg
Tablet


DIN/PIN/NPN

02526115

Manufacturer

Sanofi-Aventis Canada Inc.

Formulary Listing Date

2025-12-19  

Unit Price

376.2000

Amount MOH Pays

376.2000

Coverage Status

Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

L04AA48

Interchangeable Products

NO  

LU Clinical Criteria

NO  

Requirements


EAP Criteria

 
Therapeutic Class Reimbursement Criteria
Unclassified EAP Drugs

These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – January 1, 2025 Edition

Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding.

Product Monograph

View Monograph